Relapsing remitting multiple sclerosis (rrms) Clinical Trials

Delta Trials indexes 27 clinical trials for Relapsing remitting multiple sclerosis (rrms) in its publicly accessible dataset. Of these, 5 enrolling participants at this time and 12 trials have reached completion. This research takes place spanning 382 research sites around the world. An additional 10 trials are in preparatory or other active non-recruiting stages. Since 2020, 3 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.